Effects of Gilenya (Fingolimod) on Thalamus Pathology and Cognitive Impairment in Patients With Relapsing Forms of Multiple Sclerosis
Clinical trial NCT02021162 · COMPLETED
Trial details
- NCT number
- NCT02021162
- Sponsor
- University at Buffalo
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2013-11-01
- Primary completion
- 2018-09-01
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.